HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial

MINNEAPOLIS, United States:   HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients with pancreatic

READ MORE

Immunovia presents data from model development study at meeting of the PRECEDE pancreatic cancer research consortium

SAN DIEGO (USA) – Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, will present an update on its next-generation

READ MORE

Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference

LUND (SWEDEN) – Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today presented detailed model-development study results at the

READ MORE